DNER and diffuse large B-cell lymphoma: In order to reflect the heterogeneous expression of BCL2A1 in DLBCL, three cell lines (SUDHL2, TMD8, U2932) with varying degrees of endogenous BCL2A1 levels were selected to investigate the effect of BET inhibition (BETi) on BCL2A1 levels.